NPI: 1861875585 · LAS VEGAS, NV 89129 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/30/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/30/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,901 | $295K |
| 2019 | 26,277 | $407K |
| 2020 | 32,906 | $576K |
| 2021 | 34,894 | $523K |
| 2022 | 35,395 | $535K |
| 2023 | 18,042 | $471K |
| 2024 | 8,511 | $466K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 58,406 | 2,593 | $3.27M |
| A4657 | Syringe, with or without needle, each | 6,741 | 1,885 | $328.62 |
| G0008 | Administration of influenza virus vaccine | 222 | 106 | $311.62 |
| J1756 | Injection, iron sucrose, 1 mg | 14,460 | 1,776 | $60.00 |
| 90661 | 15 | 15 | $36.85 | |
| 83970 | 3,061 | 1,181 | $0.00 | |
| 85048 | 3,608 | 1,443 | $0.00 | |
| 85041 | 3,772 | 1,510 | $0.00 | |
| 82108 | 294 | 109 | $0.00 | |
| 83540 | 1,500 | 596 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,453 | 417 | $0.00 |
| 90662 | 31 | 12 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 24,465 | 1,203 | $0.00 |
| 82728 | 1,476 | 581 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 47,558 | 1,326 | $0.00 |
| 83550 | 944 | 446 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 536 | 132 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 323 | 122 | $0.00 |
| 90674 | 61 | 27 | $0.00 |